NEFL and amyotrophic lateral sclerosis: Several longitudinal studies following presymptomatic ALS-causing mutation carriers until the occurrence of manifest disease have aided in the understanding of the temporal profile of CSF NfL concentrations (Benatar et al., 2018, 2019).